Evaluation the effect of Fumaria Parviflora L. on post burn pruritus

Evaluation the effect of Fumaria Parviflora L. on post burn pruritus: A randomized double- blind clinical trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180609040016N2

Enrollment

Registered

2020-10-07

Start date

2020-07-22

Completion date

Unknown

Last updated

2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

1. Evaluation the effect of Fumaria Parviflora L. on post burn prurits. 2.Evaluation the effect of combination of Fumaria Parviflora L. and Terminalia Chebula Retz on post burn prurits.. Other pruritus

Interventions

Intervention 1: Intervention: Fumaria Parviflora capsule produced by Shiraz School of Pharmacy, administer two capsules before breakfast, lunch and dinner (300 mg Fmaria Parviflora powder in each caps

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: patients with post burn pruritus over 18 years old Visual Analogue Scale>=4

Exclusion criteria

Exclusion criteria: not having liver disease, kidney disease, respiratory disease, metabolic disease, hypertension, convulsion, skin diseases that lead to pruritus not having hemolytic disease

Design outcomes

Primary

Measure	Time frame
The severity of post burn pruritus. Timepoint: every two weeks. Method of measurement: Visual Analogue Scale that 0 means no itching and 10 means the most severe of itching.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRahimeh Akrami

Shiraz University of Medical Sciences

rahimeh.akrami@yahoo.com+98 71 3622 4315

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026